At a glance
ClinicalIndex Comparison RecordPhase 2Completed· 55 enrolled
Drug / intervention
CA-008 +1 moredrug
Likely dose
CA-008 5 mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Phase 2, Randomized, Double-blind, Placebo-Controlled Efficacy, Pharmacokinetics and Safety Study of CA-008 (Vocacapsaicin) in Subjects Undergoing Total Knee Arthroplasty
In Brief
A Phase 2 clinical trial evaluating CA-008 and Placebo for Postsurgical Pain. Completed, enrolled 55 participants across 1 site.
Detailed Summary
This is a two-part, Phase 2, multi-center, randomized, double-blind, placebo-controlled, parallel design study of CA-008 (vocacapsaicin) vs. placebo injected/instilled during an elective TKA.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPostsurgical Pain
CountriesUnited States
Collaborators--
Timeline
Phase 2CompletedFinished
20192020202120222023202420252026
Enrollment StartOct 2018
First PostedNov 2018
Primary CompletionApr 2019
Study CompletionMay 2019
TodayJul 2026
First PostedNov 6, 2018
Enrollment StartOct 29, 2018
Primary CompletionApr 30, 2019
Study CompletionMay 31, 2019
TodayJul 2, 2026
Enrollment to primary: 6 monthsPosted 7.7 years ago
Interventions
CA-008drug
5 mg CA-008 (0.05 mg/mL), 10 mg CA-008 (0.1 mg/mL) and 15 mg CA-008 (0.15 mg/mL)
Placebodrug
Placebo